Mmr Vaccine Market Size, Growth, Analysis, Outlook By 2019 – Trends, Opportunities And Forecast To 2027

By Author: Himanshi Arya
Total Articles: 68
Comment this article

Market Outlook:
The global MMR vaccine market was valued at USD 697.4 Million in 2019 and is projected to reach USD 938.9 Million by 2027, expanding at a CAGR of 3.8% during the forecast period. Measles, mumps, and rubella (MMR) vaccines are a fusion of live viruses that are given as an injection. Live viruses are inactivated and cannot replicate in the human cells as immune system develops a response and defends against the infection.

Market Dynamics
The market is driven by factors such as rising incidences of MMR, increasing number of patients with autoimmune disease, growing focus on immunization programs, and increasing awareness among consumers for vaccine. Conversely, high cost of vaccine development and lack of information and unavailability of vaccines in rural areas are key restraints of this market. Growth of healthcare providers in emerging markets an opportunity for vaccine manufacturer, rise in adoption of MMR Vaccine to prevent corona virus infectious disease (COVID-19), and increase in adoption of combination vaccines are boosting the market.

Segmental Outlook
On the basis ...
... of age group, the global MMR vaccine market is bifurcated into infants and preschooler. The infant segment is anticipated to expand at a CAGR of 3.7% during the forecast period due to rising government initiatives to decrease the prevalence of diseases through immunization. The preschooler segment is estimated to hold 41.0% share of the market in 2020 owing to its increasing effectiveness in immunity from the measles, mumps, and rubella.

Get Sample Copy of This Report @ https://growthmarketreports.com/request-sample/12?utm_source=medium&utm_medium=referral&utm_campaign=himanshi-a_hc_16-feb-22&utm_term=mmr-vaccine-market&utm_content=request_sample

Based on end-users, the market is segmented into hospitals, clinics, and healthcare centers. The hospital segment is projected to hold a major share of the market during the forecast period owing to the increasing incorporation of the MMR vaccine in a majority of private and public hospitals globally. The healthcare centers segment is expected to grow at a substantial pace due to improvements in infrastructure and universal healthcare systems, especially in developing countries.

Definitions

By Age Group
Infant: An infant is term used for the newborn baby or neonatal, and toddler. The infant age ranges from 12 months to 18 months are generally given the first dose of the MMR vaccine. In certain circumstances, infants can receive MMR vaccine from the age of 6 months, for example for post exposure prophylaxis Intramuscular IG (IGIM) condition. The vaccine is rarely repeated again, if the 1st dose is given at < 11 months of age. The repeat dose of MMR vaccine is not always required and is subjected to certain special cases of children. The immunization status of the infant or neonatal is determined in order to give the MMR vaccine to the baby before completing the 12months of the age. A dose provided at about 11 months of age (before 12 months of age) can provide sufficient immunogenic, particularly in infants born to mothers with vaccinated antibody measles rather than natural infection. One dose of MMR vaccine is 93% effective against measles, 78% effective against mumps, and 97% effective against rubella.

Pre-schooler: Children aged between 4 years to 6 years are termed preschoolers. Children in this age group are not considered as infants. Most of the children in this age attend formal nursery programs. In formal nursery programs, the preschoolers usually learn basic life skills, independence, and basic skills require when they proceed with primary schooling. The 2nd dose of the MMR vaccine is usually advised to be given in this period of age to children to fully prevent the body from measles, mumps, and rubella virus for a lifetime. Two doses of MMR vaccine are 97% effective against measles and 88% effective against mumps.

Enquiry before Buying This Report @ https://growthmarketreports.com/enquiry-before-buying/12?utm_source=medium&utm_medium=referral&utm_campaign=himanshi-a_hc_16-feb-22&utm_term=mmr-vaccine-market&utm_content=enquiry_before_buying

By End User

Hospital: A hospital is a health care facility that provides patients with specialist medical and nursing services, and medical facilities. Hospitals are categorized as general, specialty, or government, depending on the source of income earned. A general hospital is the most well-known type of hospital. It usually has an emergency ward to cater to urgent health problems ranging from burn and accident victims to a sudden illness. A district hospital is a healthcare facility having multiple beds for intensive care and additional beds for patients in need of long-term care. Hospitals have a number of departments (including surgery and emergency care) and specialist facilities including cardiology. Some hospitals have divisions for outpatients and others have facilities for chronic treatments. Specific units of support include pharmacy, pathology, and radiology.

Clinic: A clinic (or medical clinic or hospital clinic) is a health-care facility mainly for the treatment of the outpatient. Clinics can be run privately or controlled and financed publicly. Clinics cover the primary healthcare needs of the population in local communities by providing specialized treatments and admitting patients for overnight stays. Clinics are associated with a general practice of medicine run by one or more general practitioners. Healthcare provided in India, China, Russia, and counties in Africa through mobile health clinics or roadside dispensaries.

Healthcare center: A healthcare center, health center, or community health center is a network of clinics staffed by a group of general practitioners and nurses providing health care services to individuals in a given area. Typical services covered include family practice and dental care; however, some healthcare centers have grown considerably and include internal medicine, pediatrics, women's care, family planning, pharmacy, optometry, and laboratory testing. In countries with facilities of universal healthcare systems, most people prefer treatment from the healthcare centers. Large healthcare centers in Central and Eastern Europe are commonly called policlinics.

Regional Outlook
In terms of regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is a promising region for the market. The region constituted 50.0% share of the market in 2020. The market in the region is projected to expand at a CAGR of 4.2% during the forecast period. Increasing population and rising healthcare expenditure are driving the MMR vaccine market in Asia Pacific. The market in North America is projected to expand at a CAGR of 3.6% due growing prevalence of measles in the region.

Customization Request@ https://growthmarketreports.com/request-for-customization/12?utm_source=medium&utm_medium=referral&utm_campaign=himanshi-a_hc_16-feb-22&utm_term=mmr-vaccine-market&utm_content=customization

Competitive Landscape
• Key players in the market include GlaxoSmithKline plc., Merck & Co., Inc., Serum Institute of India Pvt. Ltd. These companies are considered manufacturers of MMR Vaccine based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.
• The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity for the MMR Vaccine extraction is added in the company’s capacity.
• For instance, in 2020, Merck & Co., Inc. completed the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation therapies for infectious diseases and cancer.
• In May 2020, GlaxoSmithKline plc. and Samsung Biologics Co. Ltd., a contract development, manufacturing, and analytical testing services company, entered into partnership for providing additional capacity of manufacturing and supplying of innovative biopharmaceutical therapies to former.

Key Benefits for Industry Participants & Stakeholders
• In-depth Analysis of the Global MMR Vaccine Market
• Historical, Current and Projected Market Size in terms of Value
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on Global MMR Vaccine Market Performance

About Growth Market Reports:
GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.

Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com
Follow Us: LinkedIn | Twitter